0JDB.L

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Pharmaceuticals

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$597M	+9.9%	$-0.84	$-0.84–$-0.84	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 7 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2024-03-06	$-0.31	$-0.31	+0.0%
2023-11-08	$-0.32	$-0.10	+68.4%
2023-08-08	$-0.37	$-0.30	+19.8%
2023-05-09	$-0.40	$-0.37	+7.9%
2023-03-01	$-0.55	$-0.41	+25.8%
2022-11-08	$-0.63	$-0.42	+33.4%
2022-08-09	$-0.76	$-0.68	+10.9%
2022-03-31	$-0.75	$-0.80	-6.3%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
0JDB.LInvitae Corporation	$0.00	-72.22%	$114597	—
0HKE.LAxon Enterprise, Inc.	$452.78	-3.77%	$35.7B	—
QRT.LThe Quarto Group, Inc.	$140.00	+12.00%	$57M	—

Source: Financial Modeling Prep · peers by sector/industry

Invitae Corporation

Invitae Corporation is a medical genetics enterprise focused on integrating genetic insights into mainstream healthcare to improve patient outcomes across the United States, Canada, and internationally. The company delivers an extensive suite of genetic tests covering diverse clinical domains, including inherited cancers, cardiac health, neurological disorders, pediatric conditions, general oncology, metabolic diseases, and rare illnesses. Beyond testing, they also offer digital health platforms and health data services. Invitae serves a broad customer base, including individual patients, healthcare providers, biopharmaceutical companies, and other collaborators. Established in 2010 as Locus Development, Inc., the company adopted the name Invitae Corporation in 2012 and is headquartered in San Francisco, California.

www.invitae.com

Employees: 1,700
IPO / List date: Jan 29, 2018
HQ: US

Held by traders on TradeandTell

No one on the platform currently holds 0JDB.L.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 0JDB.L as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 0JDB.L yet.